PolyPeptide Group AG (LTS:0AAJ) Other Long Term Assets : CHF22.7 Mil (As of Dec. 2024)

View and export this data going back to 2021. Start your Free Trial

What is PolyPeptide Group AG Other Long Term Assets?

PolyPeptide Group AG's other long-term assets for the quarter that ended in Dec. 2024 was CHF22.7 Mil.

PolyPeptide Group AG's quarterly other long-term assets increased from Dec. 2023 (CHF20.7 Mil) to Jun. 2024 (CHF21.0 Mil) and increased from Jun. 2024 (CHF21.0 Mil) to Dec. 2024 (CHF22.7 Mil).

PolyPeptide Group AG's annual other long-term assets increased from Dec. 2022 (CHF10.9 Mil) to Dec. 2023 (CHF20.7 Mil) and increased from Dec. 2023 (CHF20.7 Mil) to Dec. 2024 (CHF22.7 Mil).

PolyPeptide Group AG Other Long Term Assets Historical Data

The historical data trend for PolyPeptide Group AG's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PolyPeptide Group AG Other Long Term Assets Chart

PolyPeptide Group AG Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Other Long Term Assets

Get a 7-Day Free Trial

14.86

14.28

10.91

20.68

22.73

PolyPeptide Group AG Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Other Long Term Assets	Get a 7-Day Free Trial							10.91	12.44	20.68	21.05	22.73

PolyPeptide Group AG Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

PolyPeptide Group AG Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PolyPeptide Group AG (LTS:0AAJ) » Definitions » Other Long Term Assets

Traded in Other Exchanges

PPGNz:UK PPGN:Switzerland

Address

Neuhofstrasse 24, Baar, Zug, CHE, 6340

Website

https://www.polypeptide.com

PolyPeptide Group AG is an independent contract development and manufacturing organization (CDMO) focused on peptides and oligonucleotides employed as an active pharmaceutical ingredients (APIs) and used as intermediates in therapeutic products. The company derives majority of its revenue from Europe and Asia.

PolyPeptide Group AG Headlines

No Headlines